JW VECTAILS Trademark

Trademark Overview


On Friday, November 7, 2025, a trademark application was filed for JW VECTAILS with the United States Patent and Trademark Office. The USPTO has given the JW VECTAILS trademark a serial number of 99484392. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, June 17, 2026. This trademark is owned by JW Therapeutics (Shanghai) Co., Ltd. The JW VECTAILS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biotechnology research in the field of CAR-T cell immunotherapy, lentiviral vector platform development and gene delivery tools; Medical research in the field of CAR-T cell immunotherapy, lentiviral vector platform development and gene delivery tools; Scientific research in the nature of conducting clinical trials for others in the field of CAR-T cell immunotherapy, lentiviral vector platform development and gene delivery tools; Medical research laboratory services in the field of CAR-T cell immunotherapy, lentiviral vector platform development and gene delivery tools; Research and development of new products for others in the field of CAR-T cell immunotherapy, lentiviral vector platform development and gene delivery tools; Biochemical research and analysis in the field of CAR-T cell immunotherapy, lentiviral vector platform development and gene delivery tools
jw vectails

General Information


Serial Number99484392
Word MarkJW VECTAILS
Filing DateFriday, November 7, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, June 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiotechnology research in the field of CAR-T cell immunotherapy, lentiviral vector platform development and gene delivery tools; Medical research in the field of CAR-T cell immunotherapy, lentiviral vector platform development and gene delivery tools; Scientific research in the nature of conducting clinical trials for others in the field of CAR-T cell immunotherapy, lentiviral vector platform development and gene delivery tools; Medical research laboratory services in the field of CAR-T cell immunotherapy, lentiviral vector platform development and gene delivery tools; Research and development of new products for others in the field of CAR-T cell immunotherapy, lentiviral vector platform development and gene delivery tools; Biochemical research and analysis in the field of CAR-T cell immunotherapy, lentiviral vector platform development and gene delivery tools

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 7, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJW Therapeutics (Shanghai) Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShanghai 201210
CN

Trademark Events


Event DateEvent Description
Friday, November 7, 2025NEW APPLICATION ENTERED
Friday, November 7, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, February 11, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 19, 2026ASSIGNED TO EXAMINER
Thursday, March 19, 2026NON-FINAL ACTION WRITTEN
Thursday, March 19, 2026NON-FINAL ACTION E-MAILED
Thursday, March 19, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 17, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 17, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 17, 2026TEAS/EMAIL CORRESPONDENCE ENTERED